Trials / Completed
CompletedNCT06334744
Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the serum neutralizing antibody titre in cancer patients undergoing active treatment against variants (VOC) before and after the third dose of BNT162b2 COVID-19 vaccine.
Conditions
Timeline
- Start date
- 2021-11-17
- Primary completion
- 2023-01-08
- Completion
- 2023-06-08
- First posted
- 2024-03-28
- Last updated
- 2024-03-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06334744. Inclusion in this directory is not an endorsement.